Evidence map›Paper›PMID 42164543›Full record

ArticleMedicine and pharmacy reports2026

Renal calcifications and primary hyperpara-thyroidism in a tertiary care hospital center of North Africa: a single-center experience.

Rania El Amel, Fatim Zahra Bentebbaa, Nisrine Bouichrat, Siham Rouf, Hanane Latrech

Abstract read
In one paragraph

Article in Medicine and pharmacy reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rania El AmelDepartment of Endocrinology-Diabetology and Nutrition, Mohammed VI University Hospital Center, Faculty of Medicine and Pharmacy, University of Mohammed 1, Oujda, Morocco.
Fatim Zahra BentebbaaDepartment of Endocrinology-Diabetology and Nutrition, Mohammed VI University Hospital Center, Faculty of Medicine and Pharmacy, University of Mohammed 1, Oujda, Morocco.
Nisrine BouichratDepartment of Endocrinology-Diabetology and Nutrition, Mohammed VI University Hospital Center, Faculty of Medicine and Pharmacy, University of Mohammed 1, Oujda, Morocco.
Siham RoufDepartment of Endocrinology-Diabetology and Nutrition, Mohammed VI University Hospital Center, Faculty of Medicine and Pharmacy, University of Mohammed 1, Oujda, Morocco.
Hanane LatrechDepartment of Endocrinology-Diabetology and Nutrition, Mohammed VI University Hospital Center, Faculty of Medicine and Pharmacy, University of Mohammed 1, Oujda, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aims: Primary hyperparathyroidism (PHPT) is a common endocrine disorder; one of its common complications is renal calcifications. Our study aimed to determine the prevalence of renal calcifications (nephrolithiasis and nephrocalcinosis) in patients with primary hyperparathyroidism, to elucidate potential demographic, biochemical, radiological, and histological differences between patients with and without renal calcifications, and to assess potential risk factors associated with its occurrence. Methods: This was a retrospective, single-center, descriptive, and analytical study involving 62 patients with primary hyperparathyroidism (PHPT). Participants were assessed through serum and urinary parameters, kidney-urinary tract ultrasonography, and abdominal computed tomography (CT) scans to evaluate the presence or absence of renal calcifications. Results: We found 30 patients (48.4%) with renal calcifications, all of them nephrolithiasis, and only 2 cases (6.7%) had nephrocalcinosis associated with nephrolithiasis; and they were all detected by abdominal CT scan. Compared to patients without renal calcifications, those who had renal calcifications had a significantly higher prevalence of diabetes, BMI, waist circumference, PTH 1-84, alkaline phosphatase, and lower 25-hydroxy vitamin D (25-(OH)-D). No significant difference was found between the two groups in other studied parameters. Higher BMI and lower 25-(OH)-D were potential risk factors for renal calcifications in multivariate regression analysis. Conclusion: The combination of PHPT and renal calcifications is still common and often asymptomatic.

Indexed as

nephrocalcinosisnephrolithiasisprimary hyperparathyroidismrenal calcifications

Identifiers

PMID42164543
PMCPMC13186311

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.